Levien Willemse

Unfortunately, no medicine that can cure NET patients with metastasized NET have been developed yet. The medication that is currently used can reduce tumor growth and/or combats the symptoms of NET.


Find more information about the indications and criteria for PRRT treatment.

Stopping medication before PRRT treatment

If possible, the patient should stop taking his/her octreotide long-acting 6 weeks before the therapy. The patient needs to switch to short-acting octreotide. This has to be stopped 24 hours before the treatment, also only if clinically safe and possible. In general the patient can restart with his/her short-acting octreotide again on the day he is discharged from the hospital.


Do not stop medication without consulting a physician.


Overview PRRT Steps

For a visual overview of the various steps before, during and after treatment, view the following schematic representations:


Go to the page with required information needed for treatment.
Or go directly to the contact page for physicians.